Grants paid by Ben and Catherine Ivy Foundation
EIN 27-3322123 · Scottsdale, AZ · Form 990-PF, Part XV · NTEE T20
Ben and Catherine Ivy Foundation of Scottsdale, AZ (EIN 27-3322123) reported 124 grants paid totaling $70,445,153 to 45 recipients in tax years 2020–2025, on Form 990-PF, Part XV. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.
Grants paid
$70,445,153
124 grants
Recipients
45
distinct organizations
Tax years
2020–2025
5 filings in the corpus
By tax year
| Tax year | Grants paid | Amount paid | Approved for future |
|---|---|---|---|
| 2020 | 10 | $13,508,952 | — |
| 2022 | 24 | $15,341,725 | — |
| 2023 | 28 | $13,956,860 | — |
| 2024 | 35 | $12,169,837 | — |
| 2025 | 27 | $15,467,779 | — |
Top recipients
The 45 recipients receiving the most from Ben and Catherine Ivy Foundation, by grants paid, out of 45 distinct recipients.
| Recipient | Match | Location | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| Neuro Trials LLC | U | Phoenix, AZ | 11 | $27,360,935 | 2025 |
| Neurotrials LLC | U | Phoenix, AZ | 5 | $11,630,675 | 2025 |
| St Joseph's Foundation 94-2941245 | B | Phoenix, AZ | 6 | $7,908,660 | 2025 |
| Az Corona Virus Relief Fund | U | Phoenix, AZ | 1 | $5,000,000 | 2020 |
| Society of St Vincent de Paul 01-0964993 | C | Phoenix, AZ | 4 | $1,880,000 | 2024 |
| City of Hope Medical Center | U | Duarte, CA | 5 | $1,500,000 | 2025 |
| University of Tx Md Anderson Cancer | U | Houston, TX | 6 | $1,399,157 | 2023 |
| Johns Hopkins Hospital 52-0591656 | B | Baltimore, MD | 5 | $1,397,150 | 2025 |
| University of Virginia | U | Charlottesville, VA | 3 | $900,000 | 2023 |
| Rector Visitors of Univ of Va | U | Charlottesville, VA | 3 | $900,000 | 2024 |
| Damon Runyon Cancer Research Fdn | U | New York, NY | 5 | $750,000 | 2025 |
| Phoenix Police Foundation 86-1014450 | C | Phoenix, AZ | 2 | $719,675 | 2024 |
| Mayo Clinic College of Medicine | U | Rochester, MN | 5 | $704,182 | 2025 |
| Regents of the University of Califo 94-3067788 | C | Oakland, CA | 2 | $600,000 | 2025 |
| Md Anderson Cancer Center | U | Houston, TX | 2 | $600,000 | 2025 |
| Cleveland Clinic | U | Cleveland, OH | 2 | $600,000 | 2025 |
| Swedish Health Services 91-0433740 | C | Seattle, WA | 2 | $600,000 | 2025 |
| Children's Hospital of Philadelphia 23-1352166 | B | Philadelphia, PA | 2 | $600,000 | 2024 |
| Indiana University Foundation 35-6018940 | C | Bloomington, IN | 2 | $597,184 | 2024 |
| Mayo Clinic | U | Jacksonville, FL | 2 | $568,998 | 2023 |
| University of Michigan | U | Ann Arbor, MI | 3 | $546,800 | 2023 |
| Regents of University of Michigan 38-6006309 | D | Ann Arbor, MI | 3 | $544,734 | 2025 |
| Stanford University 26-4580872 | C | Stanford, CA | 2 | $500,000 | 2025 |
| Columbia University Irving Medical | U | New York, NY | 2 | $500,000 | 2023 |
| Mayo Clinic Jacksonville | U | Jacksonville, FL | 1 | $300,000 | 2020 |
| Univ of New Mexico Health Sciences 85-6010741 | D | Albuquerque, NM | 1 | $300,000 | 2022 |
| Univ of Miami Miller School of Medi | U | Miami, FL | 2 | $298,520 | 2023 |
| H Lee Moffitt Cancer Center | U | Rochester, MN | 2 | $294,128 | 2023 |
| Loyola University of Chicago 36-1408475 | C | Chicago, IL | 1 | $250,000 | 2025 |
| Vanderbilt University 62-0476822 | C | Nashville, TN | 1 | $250,000 | 2022 |
| Emory University | U | Atlanta, GA | 2 | $198,767 | 2023 |
| Yale Cancer Center | U | New Haven, CT | 2 | $175,680 | 2023 |
| Ut Southwestern Medical Center | U | Dallas, TX | 2 | $175,161 | 2023 |
| Gray Matters Foundation 26-0738062 | B | Scottsdale, AZ | 2 | $40,000 | 2025 |
| Arcs Foundation | U | Artesia, CA | 5 | $35,100 | 2025 |
| Archbishop Mitty High School | U | San Jose, CA | 2 | $20,000 | 2025 |
| Common Spirit Health Foundation | U | San Francisco, CA | 3 | $20,000 | 2025 |
| Barrow Neurological Fdn 86-0174371 | B | Phoenix, AZ | 1 | $4,500 | 2022 |
| Save the Bay Foundation 94-6078420 | C | Oakland, CA | 1 | $2,500 | 2024 |
| O'connor Institute | U | Phoenix, AZ | 1 | $500 | 2022 |
| Arizona Columbine Garden Club | U | Phoenix, AZ | 1 | $500 | 2024 |
| Leukemia Lymphoma Society | U | Phoenix, AZ | 1 | $250 | 2023 |
| Lucile Packard Foundation | U | Palo Alto, CA | 1 | $250 | 2024 |
| Lung Cancer Research Foundation | U | New York, NY | 1 | $150 | 2022 |
| Swedish Medical Center 91-0983214 | C | Seattle, WA | 6 | -$229,003 | 2025 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Every grant
All 124 grant rows this organization reported, most recent first.
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2025 | Neuro Trials LLC Phoenix, AZ | U | $4,300,000 | paid | SPECIAL GRANT - FUNDING FOR EMPLOYMENT AND SPECIAL NEEDS. | 202621389349100217 |
| 2025 | Neuro Trials LLC Phoenix, AZ | U | $2,755,000 | paid | 8TH INSTALLMENT PAYMENT FOR THEIVY BRAIN TUMOR CENTER. | 202621389349100217 |
| 2025 | Neurotrials LLC Phoenix, AZ | U | $2,295,000 | paid | BUILDING EXPANSION - PAYMENT #5 | 202621389349100217 |
| 2025 | Neuro Trials LLC Phoenix, AZ | U | $1,575,000 | paid | CEREBROSPINAL FLUID ANALYSIS. | 202621389349100217 |
| 2025 | St Joseph's Foundation Phoenix, AZ | B | $368,660 | paid | supports patient care, medical education, research and community outreach at St. Joseph Hospital. | 202621389349100217 |
| 2025 | City of Hope Medical Center Duarte, CA | U | $300,000 | paid | DR. BROWN - TRANSLATIONAL ADULT GLIOMA AWARD. (2ND PAYMENT) | 202621389349100217 |
| 2025 | Regents of University of Michigan Ann Arbor, MI | D | $300,000 | paid | DR. WAHL - TRANSLATIONAL ADULT GILOMA AWARD (1ST PAYMENT) | 202621389349100217 |
| 2025 | Johns Hopkins Hospital Baltimore, MD | B | $300,000 | paid | DR. ZHOU - TRANSLATIONAL ADULT GLIOMA AWARD. (1ST PAYMENT) | 202621389349100217 |
| 2025 | Md Anderson Cancer Center Houston, TX | U | $300,000 | paid | DR. CALIN - TRANSLATIONAL ADULT GLIOMA AWARD. (2ND PAYMENT) | 202621389349100217 |
| 2025 | Regents of the University of Califo Oakland, CA | C | $300,000 | paid | DR. BUTOWSKI - TRANSLATIONAL ADULT GLIOMA AWARD (2ND PAYMENT). | 202621389349100217 |
| 2025 | Cleveland Clinic Cleveland, OH | U | $300,000 | paid | DR. YU - TRANSLATIONAL ADULT GLIOMA AWARD. (2ND PAYMENT) | 202621389349100217 |
| 2025 | Neuro Trials LLC Phoenix, AZ | U | $300,000 | paid | DR. MEHTA - TRANSLATIONAL ADULT GILOMA AWARD (1ST PAYMENT) | 202621389349100217 |
| 2025 | Swedish Health Services Seattle, WA | C | $300,000 | paid | DR. PUCHALSKI - TRANSLATIONAL ADULT GLIOMA AWARD. (2ND PAYMENT) | 202621389349100217 |
| 2025 | Johns Hopkins Hospital Baltimore, MD | B | $298,575 | paid | DR. RAMAN - TRANSLATIONAL ADULT GLIOMA AWARD. (2ND PAYMENT) | 202621389349100217 |
| 2025 | Johns Hopkins Hospital Baltimore, MD | B | $250,000 | paid | DR SCHRECK - EMERGING LEADER AWARD. (2ND PAYMENT) | 202621389349100217 |
| 2025 | Stanford University Stanford, CA | C | $250,000 | paid | DR. BEINAT - EMERGING LEADER AWARD (1ST PAYMENT). | 202621389349100217 |
| 2025 | Neuro Trials LLC Phoenix, AZ | U | $250,000 | paid | DR. TOVMASYAN - EMERGING LEADER AWARD (1ST PAYMENT) | 202621389349100217 |
| 2025 | Loyola University of Chicago Chicago, IL | C | $250,000 | paid | DR. WAINWRIGHT - EMERGING LEADER AWARD (1ST PAYMENT). | 202621389349100217 |
| 2025 | Stanford University Stanford, CA | C | $250,000 | paid | DR. SOLOMON - EMERGING LEADER AWARD (1ST PAYMENT). | 202621389349100217 |
| 2025 | Damon Runyon Cancer Research Fdn New York, NY | U | $200,000 | paid | DR. JOHN PRENSNER - CLINICAL INVESTIGATOR'S AWARD. | 202621389349100217 |
| 2025 | Gray Matters Foundation Scottsdale, AZ | B | $15,000 | paid | CURRENT NEEDS: FOUNDATION supportS and empowerS Patients and their loved ones through encouragement Outreach. | 202621389349100217 |
| 2025 | Archbishop Mitty High School San Jose, CA | U | $10,000 | paid | J BENNETT - INTRO TO NEUROSCIENCE COURSE GRADE 12. | 202621389349100217 |
| 2025 | Arcs Foundation Artesia, CA | U | $8,500 | paid | 2025 - 2026 SCHOLAR AWARD. | 202621389349100217 |
| 2025 | Swedish Medical Foundation Seattle, WA | D | $5,000 | paid | SUPPORTS RESEARCH AND NONREIMBURSEABLE CLINICAL AND SUPPORTIVE CARE SERVICES. | 202621389349100217 |
| 2025 | Common Spirit Health Foundation San Francisco, CA | U | $5,000 | paid | focuses on making health equity a reality across the country. | 202621389349100217 |
| 2025 | Regents of University of Michigan Ann Arbor, MI | D | -$5,266 | paid | REFUND OF UNUSED FUNDS. | 202621389349100217 |
| 2025 | Mayo Clinic College of Medicine Rochester, MN | U | -$12,690 | paid | REFUND OF UNUSED FUNDS. | 202621389349100217 |
| 2024 | Neuro Trials LLC Phoenix, AZ | U | $2,830,000 | paid | 7TH INSTALLMENT PAYMENT FOR THEIVY BRAIN TUMOR CENTER. | 202511329349101271 |
| 2024 | Neuro Trials LLC Phoenix, AZ | U | $1,350,000 | paid | CEREBROSPINAL FLUID ANALYSIS. (3RD PAYMENT) | 202511329349101271 |
| 2024 | Society of St Vincent de Paul Phoenix, AZ | C | $1,000,000 | paid | CENTER FOR PURPOSE, HOPE AND MISSION AS PART OF THE COMMON GROUND. | 202511329349101271 |
| 2024 | St Joseph's Foundation Phoenix, AZ | B | $900,000 | paid | ST. JOSEPH'S LOBBY REMODEL. | 202511329349101271 |
| 2024 | Phoenix Police Foundation Phoenix, AZ | C | $714,675 | paid | FOR SPECIFIC NEEDS. | 202511329349101271 |
| 2024 | St Joseph's Foundation Phoenix, AZ | B | $525,000 | paid | LAB CHEMISTRY ANALYZERS, PATHOLOGY LAB SLIDE STAINER, HEMATOLOGY ANALYZER. | 202511329349101271 |
| 2024 | Neurotrials LLC Phoenix, AZ | U | $420,675 | paid | IVY BRAIN TUMOR CENTER - PHOENIX SKY HARBOR ADVERTISING FOR CLINICAL TRIALS. | 202511329349101271 |
| 2024 | Rector Visitors of Univ of Va Charlottesville, VA | U | $300,000 | paid | DR. LI - TRANSLATIONAL ADULT GLIOMA AWARD. (2ND AND LAST PAYMENT) | 202511329349101271 |
| 2024 | Regents of the University of Califo Oakland, CA | C | $300,000 | paid | DR. BUTOWSKI - 2024 TRANSLATIONAL ADULT GLIOMA AWARD. | 202511329349101271 |
| 2024 | City of Hope Medical Center Duarte, CA | U | $300,000 | paid | DR. BROWN - TRANSLATIONAL ADULT GLIOMA AWARD. (1ST PAYMENT) | 202511329349101271 |
| 2024 | Cleveland Clinic Cleveland, OH | U | $300,000 | paid | DR. YU - TRANSLATIONAL ADULT GLIOMA AWARD. (1ST PAYMENT) | 202511329349101271 |
| 2024 | City of Hope Medical Center Duarte, CA | U | $300,000 | paid | DR. BROWN - TRANSLATIONAL ADULT GLIOMA AWARD. (2ND AND LAST PAYMENT) | 202511329349101271 |
| 2024 | Children's Hospital of Philadelphia Philadelphia, PA | B | $300,000 | paid | DR. MA - TRANSLATIONAL ADULT GLIOMA AWARD. (2ND AND LAST PAYMENT) | 202511329349101271 |
| 2024 | Rector Visitors of Univ of Va Charlottesville, VA | U | $300,000 | paid | DR. SHEYBANI - TRANSLATIONAL ADULT GLIOMA AWARD. (2ND AND LAST PAYMENT) | 202511329349101271 |
| 2024 | Md Anderson Cancer Center Houston, TX | U | $300,000 | paid | DR. CALIN - TRANSLATIONAL ADULT GLIOMA AWARD. (1ST PAYMENT) | 202511329349101271 |
| 2024 | Swedish Health Services Seattle, WA | C | $300,000 | paid | DR. PUCHALSKI - TRANSLATIONAL ADULT GLIOMA AWARD. (1ST PAYMENT) | 202511329349101271 |
| 2024 | Rector Visitors of Univ of Va Charlottesville, VA | U | $300,000 | paid | DR. AMOUNADER - TRANSLATIONAL ADULT GLIOMA AWARD. (2ND AND LAST PAYMENT) | 202511329349101271 |
| 2024 | Indiana University Foundation Bloomington, IN | C | $298,592 | paid | DR. HAO - TRANSLATIONAL ADULT GLIOMA AWARD. (2ND AND LAST PAYMENT) | 202511329349101271 |
| 2024 | Johns Hopkins Hospital Baltimore, MD | B | $298,575 | paid | DR. RAMAN - TRANSLATIONAL ADULT GLIOMA AWARD. (1ST PAYMENT) | 202511329349101271 |
| 2024 | Regents of University of Michigan Ann Arbor, MI | D | $250,000 | paid | DR. WAHL - EMERGING LEADER AWARD. (2ND AND LAST PAYMENT) | 202511329349101271 |
| 2024 | Johns Hopkins Hospital Baltimore, MD | B | $250,000 | paid | DR SCHRECK - EMERGING LEADER AWARD. (1ST PAYMENT) | 202511329349101271 |
| 2024 | Damon Runyon Cancer Research Fdn New York, NY | U | $200,000 | paid | DR. JOHN PRENSNER - CLINICAL INVESTIGATOR'S AWARD. | 202511329349101271 |
| 2024 | Swedish Medical Center Seattle, WA | C | $150,000 | paid | HIGH-THROUGHPUT SCREENING (HTS) CLINICAL TRIAL TREATING RECURRENT GBM PATIENTS. | 202511329349101271 |
| 2024 | Gray Matters Foundation Scottsdale, AZ | B | $25,000 | paid | CURRENT NEEDS: FOUNDATION supportS and empowerS Patients and their loved ones through encouragement Outreach. | 202511329349101271 |
| 2024 | Archbishop Mitty High School San Jose, CA | U | $10,000 | paid | J BENNETT - INTRO TO NEUROSCIENCE COURSE GRADE 12. | 202511329349101271 |
| 2024 | St Joseph's Foundation Phoenix, AZ | B | $10,000 | paid | supports patient care, medical education, research and community outreach at St. Joseph Hospital. | 202511329349101271 |
| 2024 | Common Spirit Health Foundation San Francisco, CA | U | $10,000 | paid | focuses on making health equity a reality across the country. | 202511329349101271 |
| 2024 | Arcs Foundation Artesia, CA | U | $8,500 | paid | 2024 - 2025 SCHOLAR AWARD. | 202511329349101271 |
| 2024 | Phoenix Police Foundation Phoenix, AZ | C | $5,000 | paid | GREATEST NEED:FOUNDATION FUNDS ESSENTIONAL EQUIPMENT AND TECHNOLOGY, PROVIDES FINANCIAL ASSISTANCE TO EMPLOYEES AND THEIR FAMILIES, AND RECOGNIZES THOSE WHO DEMONSTRATE EXCEPTIONAL COURAGE. | 202511329349101271 |
| 2024 | Save the Bay Foundation Oakland, CA | C | $2,500 | paid | ADVOCATE FOR THE BAY AREA BY CALLING FOR POLICIES AND FUNDING TO CREATE A RESILIENT, SUSTAINABLE AND EQUITABLE BAY AREA. | 202511329349101271 |
| 2024 | Swedish Medical Foundation Seattle, WA | D | $1,545 | paid | SUPPORTS RESEARCH AND NONREIMBURSEABLE CLINICAL AND SUPPORTIVE CARE SERVICES. | 202511329349101271 |
| 2024 | Arizona Columbine Garden Club Phoenix, AZ | U | $500 | paid | TO STIMULATE THE KNOWLEDGE AND LOVE OF GARDENING AND AID IN THE PROTECTION OF NATIVE TREES, PLANTS AND SHRUBS. | 202511329349101271 |
| 2024 | Arcs Foundation Artesia, CA | U | $500 | paid | PROVIDES AWARDS TO ACADEMICALLY OUTSTANDING US CITIZENS STUDYING TO COMPLETE DEGREES IN SCIENCE, ENGINEERING AND MEDICAL. | 202511329349101271 |
| 2024 | Lucile Packard Foundation Palo Alto, CA | U | $250 | paid | MAKE HEALTH CARE MORE ACCESSIBLE FOR CHILDREN WITH COMPLEX MEDICAL NEEDS. | 202511329349101271 |
| 2024 | Mayo Clinic College of Medicine Rochester, MN | U | -$91,475 | paid | REFUND OF UNUSED FUNDS. | 202511329349101271 |
| 2023 | St Joseph's Foundation Phoenix, AZ | B | $5,970,000 | paid | IVY BRAIN TUMOR CENTER AT BARROW NEUROLOGICAL INSTITUTE CAPITAL EXPENDITURES. | 202421929349101307 |
| 2023 | Neuro Trials LLC Phoenix, AZ | U | $3,800,935 | paid | MULTIPLE AWARDS:1) DEVELOPMENT OF TRIPLE-DRUG COCKTAILS TO INDUCE GLIOBLASTOMA.2) UCSF PRECLINICAL CORE FOR DRUG DEVELOPMENT AT THE IVY BRAIN TUMOR CENTER.3)10 YEAR IBTC GRANT4) MATCHING FUNDS NATIONAL GBM DAY | 202421929349101307 |
| 2023 | Society of St Vincent de Paul Phoenix, AZ | C | $380,000 | paid | CENTER FOR FAMILY WELLNESS ESTABLISHED TO FOCUS ON THE PREVENTION AND MANAGEMENT OF CHRONIC DISEASES THROUGH NUTRITION, PHYSICAL ACTIVITY AND OVERALL WELLNESS. ITS CULTURALLY GROUNDED BILINGUAL EDUCATION PROGRAMS ENCOURAGE THE WHOLE FAMILY TO PARTICIPATE. | 202421929349101307 |
| 2023 | Swedish Medical Center Seattle, WA | C | $300,500 | paid | ASSESS COMBINATIONS OF SMALL MOLECULES AND IMMUNOTHERAPIES FOR KILLING GLIOBLASTOMA TUMOR CELLS IN A PERSONALIZED EX VIVO ECOSYSTEM WITH INTACT TUMOR MICROENVIRONMENT USING MULTIPLEX IMMUNOCHEMISTRY AND SPATIAL MAPPING OF CELL TYPES. | 202421929349101307 |
| 2023 | University of Virginia Charlottesville, VA | U | $300,000 | paid | DEVELOP SMALL MOLECULE INHIBITORS OF A NEWLY IDENTIFIED ONCOGENE IN GLIOBLASTOMA. PMT 1 OF 2. | 202421929349101307 |
| 2023 | University of Virginia Charlottesville, VA | U | $300,000 | paid | DEVELOP AND DEPLOY STRATEGIES FOR LEVERAGING MRI-GUIDED FOCUSED ULTRASOUND THERAPY TO POTENTIATE CAR-T CELL THERAPY AGAINST ADULT HIGH-GRADE GLIOMAS. PMT 1 OF 2. | 202421929349101307 |
| 2023 | City of Hope Medical Center Duarte, CA | U | $300,000 | paid | PHASE I CLINICAL TRIAL TO EVALUATE THE FEASIBILITY, SAFETY, AND CLINICAL EFFICACY OF TGF-RESISTANT ILIRa2-CAR T CELLS FOR TREATMENT OF RECURRENT GLIOBLASTOMA. PMT #1 OF 2. | 202421929349101307 |
| 2023 | Mayo Clinic College of Medicine Rochester, MN | U | $300,000 | paid | EVALUATE CANDIDATE GLIOMA CSF PROTEOMIC SIGNATURES TO HELP UNDERSTAND AND MONITOR GLIOMA EVOLUTION IN LIVING PATIENTS DURING STANDARD OF CARE AND EXPERIMENTAL IMMUNOTHERAPY. PAYMENT 2 OF 2. | 202421929349101307 |
| 2023 | University of Tx Md Anderson Cancer Houston, TX | U | $300,000 | paid | PROJECT SEEKS TO PRECLINICALLY OPTIMIZE NOVEL THERAPEUTIC APPROACHES FOR ATRX-DEFICIENT MALIGNANT GLIOMAS TARGETING G-QUADRUPLEX DNA SECONDARY STRUCTURE. PAYMENT 2 OF 2. | 202421929349101307 |
| 2023 | Children's Hospital of Philadelphia Philadelphia, PA | B | $300,000 | paid | ENGINEERING A MULTI-ANTIGEN TARGETING CAR T THERAPY WITH CONFINED ACTIVITES WITHIN THE TUMOR MICROENVIRONMENT TO TREAT ANTIGENICALLY HETEROGENOUS ADULT GLIOBLASTOMA. | 202421929349101307 |
| 2023 | University of Virginia Charlottesville, VA | U | $300,000 | paid | DEVELOP AND TEST NEW THERAPIES FOR GLIOBLASTOMA USING MICORNAS. PMT 1 OF 2. | 202421929349101307 |
| 2023 | Mayo Clinic Jacksonville, FL | U | $300,000 | paid | IDENTIFY THE ONCOGENIC SIGNALING DEPENDENCIES THAT CHARACTERIZE EACH OF THE CELLULAR SUBPOPULATIONS THAT COMPRISE A GLIOBLASTOMA TUMOR, AND FROM THIS INFORMATION CONSTRUCT A NON-TOXIC COMBINATION OF KINASE INHIBITORS TO EFFECTIVELY TREAT THIS DISEASE. PAYMENT 2 OF 2. | 202421929349101307 |
| 2023 | Indiana University Foundation Bloomington, IN | C | $298,592 | paid | DETERMINE THE STRUCTURAL BASIS AND MOLECULAR MECHANISM OF ACTION OF SUM01 DEGRADERS IN TREATMENT OF GLIOBLASTOMA, ALONE AND IN COMBINATION WITH CURRENT STANDARD CHEMO AND RADIOTHERAPY. | 202421929349101307 |
| 2023 | Columbia University Irving Medical New York, NY | U | $250,000 | paid | TARGETING THE GLIOBLASTOMA MASTER REGULATOR CEBP A PHARMACOKINETICS AND PHARMACODYNAMICS SURGICAL STUDY OF ST101. PAYMENT 2 OF 2. | 202421929349101307 |
| 2023 | University of Michigan Ann Arbor, MI | U | $250,000 | paid | DEVELOP QUANTITATIVE METHODS TO ASSESS METHIONNINE METABOLISM AND TEST THE EFFICACY OF METHIONNE-DIRECTED THERAPEUTICS IN MOUSE MODELS AND PATIENTS WITH GLIOBLASTOMA. PMT 1 OF 2. | 202421929349101307 |
| 2023 | University of Tx Md Anderson Cancer Houston, TX | U | $250,000 | paid | DEVELOP SAFE AND POTENT DRUGS THAT CAN TURN THE TUMOR IMMUNE MICROENVIRONMENT FROM SUPPRESSIVE TO PERMISSIVE, THEREBY HELPING THE IMMUNE SYSTEM TO RECOGNIZE AND KILL GLIOBLASTOMA. PAYMENT 2 OF 2. | 202421929349101307 |
| 2023 | St Joseph's Foundation Phoenix, AZ | B | $135,000 | paid | supports patient care, medical education, research and community outreach at St. Joseph Hospital. | 202421929349101307 |
| 2023 | Damon Runyon Cancer Research Fdn New York, NY | U | $130,000 | paid | INVESTIGATION OF A BIOMARKER PHASE 2 STUDY TO EVALUATE TARGETED THERAPY HARBORING SPECIFIC GENETIC ALTERATIONS. 4TH AND FINAL PMT. | 202421929349101307 |
| 2023 | Arcs Foundation Artesia, CA | U | $8,800 | paid | ADVANCE SCIENCE AND TECHNOLOGY IN THE UNITED STATES BY PROVIDING AWARDS TO ACADEMICALLY OUTSTANDING US CITIZENS STUDYING TO COMPLETE DEGREES IN SCIENCE, ENGINEERING AND MEDICAL RESEARCH. | 202421929349101307 |
| 2023 | Common Spirit Health Foundation San Francisco, CA | U | $5,000 | paid | focused on making health equity a reality across the country through pioneering programs that ensure greater access to care, create community partnerships and participation and advocate for those who are vulnerable. | 202421929349101307 |
| 2023 | Leukemia Lymphoma Society Phoenix, AZ | U | $250 | paid | supports the development of new treatments for cancer and breaking down the barriers to care that patients often encounter. | 202421929349101307 |
| 2023 | University of Tx Md Anderson Cancer Houston, TX | U | -$843 | paid | REFUND OF UNUSED FUNDS. | 202421929349101307 |
| 2023 | Univ of Miami Miller School of Medi Miami, FL | U | -$1,480 | paid | REFUND OF UNUSED FUNDS. | 202421929349101307 |
| 2023 | University of Michigan Ann Arbor, MI | U | -$3,200 | paid | REFUND OF UNUSED FUNDS. | 202421929349101307 |
| 2023 | H Lee Moffitt Cancer Center Rochester, MN | U | -$5,872 | paid | REFUND OF UNUSED FUNDS. | 202421929349101307 |
| 2023 | Ut Southwestern Medical Center Dallas, TX | U | -$35,269 | paid | REFUND OF UNUSED FUNDS. | 202421929349101307 |
| 2023 | Emory University Atlanta, GA | U | -$51,233 | paid | REFUND OF UNUSED FUNDS. | 202421929349101307 |
| 2023 | Yale Cancer Center New Haven, CT | U | -$124,320 | paid | REFUND OF UNUSED FUNDS. | 202421929349101307 |
| 2022 | Neurotrials LLC Phoenix, AZ | U | $5,470,000 | paid | PREPAYMENT OF 2023 CEREBROSPINAL FLUID ANALYSIS. | 202312089349100511 |
| 2022 | Neuro Trials LLC Phoenix, AZ | U | $5,000,000 | paid | IVY BRAIN TUMOR CENTER BUILDING EXPANSION SPECIAL GRANT AMENDMENT. | 202312089349100511 |
| 2022 | Neurotrials LLC Phoenix, AZ | U | $450,000 | paid | CEREBROSPINAL FLUID ANALYSIS WITH T-GEN. | 202312089349100511 |
| 2022 | Mayo Clinic College of Medicine Rochester, MN | U | $300,000 | paid | EVALUATE CANDIDATE GLIOMA CSF PROTEOMIC SIGNATURES TO HELP UNDERSTAND AND MONITOR GLIOMA EVOLUTION IN LIVING PATIENTS DURING STANDARD OF CARE AND EXPERIMENTAL IMMUNOTHERAPY. PAYMENT 1 OF 2. | 202312089349100511 |
| 2022 | Univ of New Mexico Health Sciences Albuquerque, NM | D | $300,000 | paid | IDENTIFY MECHANISMS UNDERLYING INFLAMMATORY CELL CONTRIBUTION TO THE EMERGENCE OF THE RECURRENT TUMOR BY SINGLE-CELL ANALYSIS OF RESIDUAL DISEASE IN GLIOBLASTOMA PATIENTS. PAYMENT 2 OF 2. | 202312089349100511 |
| 2022 | University of Michigan Ann Arbor, MI | U | $300,000 | paid | NEW METHODS WILL BE DEVELOPED TO MEASURE THE ACTIVITY OF TUMOR METABOLIC PATHWAYS IN PATIENTS WITH GLIOBLASTOMA AND TO DETERMINE WHETHER DRUGS DESIGNED TO BLOCK THESE PATHWAYS ARE SUITABLE. PAYMENT 2 OF 2. | 202312089349100511 |
| 2022 | University of Tx Md Anderson Cancer Houston, TX | U | $300,000 | paid | PROJECT SEEKS TO PRECLINICALLY OPTIMIZE NOVEL THERAPEUTIC APPROACHES FOR ATRX-DEFICIENT MALIGNANT GLIOMAS TARGETING G-QUADRUPLEX DNA SECONDARY STRUCTURE. PAYMENT 1 OF 2. | 202312089349100511 |
| 2022 | Swedish Medical Center Seattle, WA | C | $300,000 | paid | ASSESS COMBINATIONS OF SMALL MOLECULES AND IMMUNOTHERAPIES FOR KILLING GLIOBLASTOMA TUMOR CELLS IN A PERSONALIZED EX VIVO ECOSYSTEM WITH INTACT TUMOR MICROENVIRONMENT USING MULTIPLEX IMMUNOCHEMISTRY AND SPATIAL MAPPING OF CELL TYPES. PAYMENT 1 OF 2. | 202312089349100511 |
| 2022 | Univ of Miami Miller School of Medi Miami, FL | U | $300,000 | paid | USING PATIENT DERIVED ORTHOTOPIC XENOGRAFT MODELS AND A NOVEL IMMUNOCOMPETENT MODEL OF GBM, THE EFFICACY OF A MTl-MMP INHIBITOR IN COMBINATION WITH RADIATION/TMZ WILL BE TESTED TO DETERMINE ITS EFFECTS ON THE IMMUNE COMPONENT OF THE TUMOR MICROENVIRONMENT. PAYMENT 2 OF 2. | 202312089349100511 |
| 2022 | H Lee Moffitt Cancer Center Rochester, MN | U | $300,000 | paid | IN EXAMINING THE ROLE OF TUMORS CELLS IN MODULATING BONE MARROW-DERIVED MACROPHAGES AND MICROGLIA, THIS STUDY SEEKS TO TAILOR NOVEL THERAPEUTICS FOR TARGETING OF TUMOR ASSOCIATED MACROPHAGES. PAYMENT 2 OF 2. | 202312089349100511 |
| 2022 | Yale Cancer Center New Haven, CT | U | $300,000 | paid | USE OF A NOVEL TRANSFORMATIONAL PLATFORM FOR RAPID IDENTIFICATION OF TARGETS AND TREATMENTS TO INHIBIT GROWTH AND INVASION OF GLIOBLASTOMA CELLS BASED ON RAPID PATIENT SAMPLE SCREENING USING NOVEL NANO-ENGINEERING TECHNIQUES. PAYMENT 2 OF 2. | 202312089349100511 |
| 2022 | Mayo Clinic Jacksonville, FL | U | $268,998 | paid | IDENTIFY THE ONCOGENIC SIGNALING DEPENDENCIES THAT CHARACTERIZE EACH OF THE CELLULAR SUBPOPULATIONS THAT COMPRISE A GLIOBLASTOMA TUMOR, AND FROM THIS INFORMATION CONSTRUCT A NON-TOXIC COMBINATION OF KINASE INHIBITORS TO EFFECTIVELY TREAT THIS DISEASE. PAYMENT 1 OF 2. | 202312089349100511 |
| 2022 | University of Tx Md Anderson Cancer Houston, TX | U | $250,000 | paid | DEVELOP SAFE AND POTENT DRUGS THAT CAN TURN THE TUMOR IMMUNE MICROENVIRONMENT FROM SUPPRESSIVE TO PERMISSIVE, THEREBY HELPING THE IMMUNE SYSTEM TO RECOGNIZE AND KILL GLIOBLASTOMA. PAYMENT 1 OF 2. | 202312089349100511 |
| 2022 | Society of St Vincent de Paul Phoenix, AZ | C | $250,000 | paid | CENTER FOR FAMILY WELLNESS ESTABLISHED TO FOCUS ON THE PREVENTION AND MANAGEMENT OF CHRONIC DISEASES THROUGH NUTRITION, PHYSICAL ACTIVITY AND OVERALL WELLNESS. ITS CULTURALLY GROUNDED BILINGUAL EDUCATION PROGRAMS ENCOURAGE THE WHOLE FAMILY TO PARTICIPATE. PAYMENT #3. | 202312089349100511 |
| 2022 | Vanderbilt University Nashville, TN | C | $250,000 | paid | USING SINGLE-CELL AND SYSTEMS BIOLOGY APPROACHES IN GLIOBLASTOMA, CELL SUBTYPES WILL BE MAPPED TO GLIOBLASTOMA TISSUES AND EXPERIMENTAL MODELS, ENABLING IDENTIFICATION AND PRECLINICAL TARGETING OF INTERACTIONS BETWEEN CANCER CELLS, IMMUNE CELLS, AND LOCATION SPECIFIC RESIDENT BRAIN CELLS. PAYMENT 2 OF 2. | 202312089349100511 |
| 2022 | Columbia University Irving Medical New York, NY | U | $250,000 | paid | TARGETING THE GLIOBLASTOMA MASTER REGULATOR CEBP A PHARMACOKINETICS AND PHARMACODYNAMICS SURGICAL STUDY OF ST101. PAYMENT 1 OF 2. | 202312089349100511 |
| 2022 | Ut Southwestern Medical Center Dallas, TX | U | $210,430 | paid | PRECLINICAL INVESTIGATION OF FOCUS ULTRASOUND GUIDED DELIVERY TO FACILITATE A LIPOPROTEIN-OMEGA-3 FATTY ACID-BASED BIOLOGICAL THERAPY IN GLIOBLASTOMA. PAYMENT 2 OF 2. | 202312089349100511 |
| 2022 | Mayo Clinic College of Medicine Rochester, MN | U | $208,347 | paid | IMMUNOSTIMULATORY BACTERIAL ANTIGENS EXPRESSED IN ONCOLYTIC VIRAL PLATFORMS WILL BE TESTED IN PRECLINICAL MODELS OF GLIOBLASTOMA TO OVERCOME IMMUNE CHECKPOINT INHIBITOR RESISTANCE. PAYMENT 2 OF 2. | 202312089349100511 |
| 2022 | Neuro Trials LLC Phoenix, AZ | U | $200,000 | paid | DEPOSIT FOR IVY BRAIN TUMOR CENTER BUILDING LOBBY. | 202312089349100511 |
| 2022 | Damon Runyon Cancer Research Fdn New York, NY | U | $120,000 | paid | INVESTIGATION OF A BIOMARKER PHASE 2 STUDY TO EVALUATE TARGETED THERAPY HARBORING SPECIFIC GENETIC ALTERATIONS. PAYMENT 3 | 202312089349100511 |
| 2022 | Arcs Foundation Artesia, CA | U | $8,800 | paid | ADVANCE SCIENCE AND TECHNOLOGY IN THE UNITED STATES BY PROVIDING AWARDS TO ACADEMICALLY OUTSTANDING US CITIZENS STUDYING TO COMPLETE DEGREES IN SCIENCE, ENGINEERING AND MEDICAL RESEARCH. | 202312089349100511 |
| 2022 | Barrow Neurological Fdn Phoenix, AZ | B | $4,500 | paid | PROVIDES PHILANTHROPIC SUPPORT FOR BARROW NEUROLOGICAL INSTITUTE AT ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER. BARROW IS AN INTERNATIONAL LEADER IN THE TREATMENT, RESEARCH, AND EDUCATION OF BRAIN AND SPINAL DISEASES, CONDITIONS AND INJURIES. | 202312089349100511 |
| 2022 | O'connor Institute Phoenix, AZ | U | $500 | paid | ADVANCES SANDRA DAY O'CONNOR'S DISTINGUISHED LEGACY AND LIFETIME WORK TO ADVANCE CIVICS EDUCATION, CIVIC ENGAGEMENT AND CIVIL DISCOURSE. | 202312089349100511 |
| 2022 | Lung Cancer Research Foundation New York, NY | U | $150 | paid | IMPROVES LUNG CANCER OUTCOMES BY FUNDING RESEARCH FOR THE PREVENTION, DIAGNOSIS, TREATMENT AND CURE OF LUNG CANCER. | 202312089349100511 |
| 2020 | Az Corona Virus Relief Fund Phoenix, AZ | U | $5,000,000 | paid | DIRECT COSTS FOR PERSONAL PROTECTION EQUIPMENT AND MASKS FOR ARIZONA HOSPITALS. | 202242639349100714 |
| 2020 | Neuro Trials LLC Phoenix, AZ | U | $5,000,000 | paid | BUILDING EXPANSION. | 202242639349100714 |
| 2020 | Neurotrials LLC Phoenix, AZ | U | $2,995,000 | paid | ESTABLISH A PHOENIX-BASED CENTER FOR GLIOBLASTOMA DRUG DISCOVERY (THE IVY BRAIN TUMOR RESEARCH CENTER) EMPHASIZING INDUSTRY -PARTNERED DRUG DEVELOPMENT PAIRED WITH A LARGE PORTFOLIO OF PHASE 0/II TRIALS AND RANDOMIZED PHASE II TRIALS. | 202242639349100714 |
| 2020 | University of Tx Md Anderson Cancer Houston, TX | U | $300,000 | paid | (YEAR 1 OF 2) AMY HEIMBERGER MD - THE USE OF STAT 3 INHIBITION IN COMBINATION WITH RADIATION TO INDUCE ANTIGEN PRESENTING CELL-T CELL IMMUNOLOGICAL SYNAPSES AND SUBSEQUENT T CELL ACTIVATION IN THE GLIOMA MICROENVIRONMENT. | 202242639349100714 |
| 2020 | Mayo Clinic Jacksonville Jacksonville, FL | U | $300,000 | paid | (YEAR 1 OF 2) DR ROSENFELD - DEVELOPMENT OF A TRANSCRIPTOMICALLY-GUIDED THERAPEUTIC STRATEGY THAT COMBINES TARGETED THERAPIES THAT BOTH EFFECTIVELY TREAT GLIOBLASTOMA AND PREVENT THE EMERGENCE OF TREATMENT RESISTANCE. | 202242639349100714 |
| 2020 | City of Hope Medical Center Duarte, CA | U | $300,000 | paid | RENEE POWER(EMERGING LEADER AWARD) ADVANCING IL13RA2-CAR T THERAPY. | 202242639349100714 |
| 2020 | Society of St Vincent de Paul Phoenix, AZ | C | $250,000 | paid | CENTER FOR FAMILY WELLNESS ESTABLISHED TO FOCUS ON THE PREVENTION AND MANAGEMENT OF CHRONIC DISEASES THROUGH NUTRITION, PHYSICAL ACTIVITY AND OVERALL WELLNESS. ITS CULTURALLY GROUNDED BILINGUAL EDUCATION PROGRAMS ENCOURAGE THE WHOLE FAMILY TO PARTICIPATE. | 202242639349100714 |
| 2020 | Emory University Atlanta, GA | U | $250,000 | paid | (YEAR 1 OF 2)DR RENEE READ EMERGING LEADER AWARD - USING PRE-CLINICAL EXPERIMENTAL MODELS TO IDENTIFY BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSE TO AN FDA-APPROVED LIPOSOMAL FORMULATION OF VERTEPORFIN. | 202242639349100714 |
| 2020 | Damon Runyon Cancer Research Fdn New York, NY | U | $100,000 | paid | INVESTIGATION OF A BIOMARKER PHASE 2 STUDY TO EVALUATE TARGETED THERAPY HARBORING SPECIFIC GENETIC ALTERATIONS. | 202242639349100714 |
| 2020 | Swedish Medical Center Seattle, WA | C | -$986,048 | paid | RETURN OF UNUSED FUNDS. | 202242639349100714 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Source filings
Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.
| Form | Tax year | Period end | Filed | Schema | IRS OBJECT_ID |
|---|---|---|---|---|---|
| 990PF | 2025 | 2025-12-31 | not stated | 2025v4.1 | 202621389349100217 |
| 990PF | 2024 | 2024-12-31 | not stated | 2024v5.1 | 202511329349101271 |
| 990PF | 2023 | 2023-12-31 | not stated | 2023v5.1 | 202421929349101307 |
| 990PF | 2022 | 2022-12-31 | not stated | 2022v5.0 | 202312089349100511 |
| 990PF | 2020 | 2020-12-31 | not stated | 2020v4.0 | 202242639349100714 |
Derived from IRS Form 990-PF e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/273322123.json.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.